MedTrace Logo

Lead Exposure and Multiple Sclerosis

NCT07423312 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 140

Last updated 2026-02-20

No results posted yet for this study

Summary

1. To evaluate the effect of lead level on the pathogenesis of multiple sclerosis
2. Measure lead in blood sample of study groups
3. Estimate the expression level of DNA methyltransferase.
4. Evaluate oxidative stress markers, like MDA/8-OHdG
5. Measureδ-aminolevulinic acid
6. Correlate the clinical data of patients with biochemical markers

Conditions

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Ragaa Hamdy Mohamed Salama, prof. · Assiut University

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-12-30
Primary Completion
2028-12-30
Completion
2029-05-05

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07423312 on ClinicalTrials.gov